Trials / Terminated

TerminatedNCT01844037

OneShot Renal Denervation Registry

Renal Denervation Using the OneShot Ablation System

Status: Terminated
Phase: Phase 2 / Phase 3
Study type: Interventional
Enrollment: 51 (actual)

Sponsor: Medtronic Endovascular · Industry
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

This is a multi-center, prospective registry designed to monitor the outcomes of renal denervation with the OneShot Device in a real-world patient population.

Conditions

Hypertension
Heart Failure
Diabetes Mellitus
Sleep Apnea

Interventions

Type	Name	Description
DEVICE	OneShot Ablation System	Renal denervation

Timeline

Start date: 2014-07-01
Primary completion: 2015-03-01
Completion: 2015-03-01
First posted: 2013-05-01
Last updated: 2015-09-02

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT01844037. Inclusion in this directory is not an endorsement.